Metropolis Healthcare, incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 6731.32 Crore) operating in Hospitals...

Promoters held 49.79 per cent stake in the company as of 30-Jun-2022, while FIIs owned 23.2 per cent, DIIs 14.5 per cent.

According to documents accessed by CRE Matrix, a real estate data analytics firm, Star hotel PVR Ltd has sold the bungalow and property has...

Metropolis chief executive Ameera Shah and her family has initiated a formal process to sell part of the promoter stake and is understood t...

The company is in early discussions with several global strategic investors and other potential purchasers of the shares, said the people, ...

Suresh Narayanan, chairman and managing director, Nestle India won the Entrepreneurial CEO award and Byju Raveendran, founder and chief exe...

The Metropolis Healthcare MD says that it's important to talk about mistakes as well.

The quota for qualified institutional buyers (QIBs) was over subscribed 8.8 times.

Metropolis was exploring a consolidation deal which could make it the largest diagnostics chain in Asia’s third-largest economy, sources sa...

The re-entry puts him in direct competition with his former partner, Ameera Shah.

The boardroom can be a tough place for women, even for those with famous dads.

They are not afraid of taking business risks or foraying into newer businesses and have created environment and pushed for HR reforms targe...

Global private equity fund Carlyle is buying 37% stake in diagnostics chain Metropolis from one of its founders GSK Velu.

Metropolis s today a multinational chain with more than 125 laboratories, tracking Rs 600-crore revenue annually.

Dr GSK Velu has reacted angrily to last week’s transaction between Warburg and the Shah family, which resulted in the Shahs increasing thei...

The dealmaking in Metropolis coincides with IPO plans of other players, notably Dr Lal Pathlabs, SRL and Thyrocare, all of whom could list ...